PISCATAWAY, N.J. 鈥� Camber Pharmaceuticals continues to strengthen its range of treatment options with the introduction of Nilotinib Capsules [nye-LOE-ti-nib].
Nilotinib is indicated for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in pediatric patients greater than or equal to 1 year of age and adults, across various disease stages, disease progression, and prior treatment.
For complete indications, click .
Nilotinib capsules are available in 150 mg and 200 mg strengths, each supplied in 4 blister packs of 28 capsules.
Product Link:
